Jiangxi Provincial Cancer Hospital

Recent papers from Jiangxi Provincial Cancer Hospital

1. CACA guidelines for holistic integrative management of PET imagingHolistic Integrative Oncology · 2026
2. An evidence-gated strategy for translating targeted oncologic PET radiopharmaceuticals from molecular design to clinical useFrontiers in Nuclear Medicine · 2026
3. Comparative efficacy of gut microbiota-targeted therapies for motor and non-motor symptoms in Parkinson's disease: a systematic review and network meta-analysisFrontiers in Microbiology · 2026
4. Trastuzumab Rezetecan in ERBB2-Low Advanced Breast CancerJAMA · 2026
5. Value of Multimodal Ultrasound Imaging With Super‐Resolution in the Differential Diagnosis of Benign and Malignant Superficial Lymph NodesJournal of Ultrasound in Medicine · 2026
6. From Efficacy to Effectiveness in Gynecologic Oncology: Social Determinants, Therapeutic Transportability, and Biological WeatheringThe Oncologist · 2026
7. Ecological Editing: Decoupling Microbial Signals from Metabolic Noise to Reprogram the Gut EcosystemMicroorganisms · 2026
8. CT-derived spatial intratumoural heterogeneity and KRAS mutation status in a predominantly lung adenocarcinoma cohort: an exploratory study of association and incremental discriminationBMC Medical Imaging · 2026
9. GClnc1 as an emerging oncogenic regulator with mechanistic insights and clinical implications in human cancersiScience · 2026
10. Retrospective observational study of transcatheter arterial chemoembolization (TACE) combined with PD-1 inhibitor and tyrosine kinase inhibitor (TKI) in advanced hepatocellular carcinomaMedicine · 2026
11. Dose–response relationships between temporal variables of blood flow restriction exercise and physiological adaptations: a systematic review and meta-analysisFrontiers in Physiology · 2026
12. Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a detailed safety analysis of the randomized OptiTROP-Breast01 studyBreast Cancer Research · 2026
13. ZBTB1 Regulates Glycolysis and Chemotherapy Resistance Through Interacting with c-Myc in Triple Negative Breast CancerCancers · 2026
14. Preoperative CT deep learning of tumor and visceral adipose tissue combined with postoperative pathology predicts colorectal cancer recurrence: a multicenter studyFrontiers in Molecular Biosciences · 2026
15. Neoadjuvant disitamab vedotin (RC-48) plus a PD-1 inhibitor in muscle-invasive bladder cancer: a multicenter real-world study with stratification by HER2 expression and tertiary lymphoid structuresFrontiers in Immunology · 2026
16. Cancer-associated fibroblasts drive immune resistance in MSS colorectal cancer via the FAIM2-CES1-ER stress pathwayMolecular and Cellular Biochemistry · 2026
17. Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled TrialJournal of Clinical Oncology · 2026
18. Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based TherapyNew England Journal of Medicine · 2026
19. Bibliometric study on the relationship between hepatocellular carcinoma and lipid metabolism based on CiteSpaceDiscover Oncology · 2026
20. An interpretable deep learning model based on enhanced CT predicts the recurrence of non-muscle-invasive bladder cancer within 2 yearsBMC Medical Imaging · 2026